142 related articles for article (PubMed ID: 23751854)
1. Past exposure to hepatitis B: a risk factor for increase in mortality?
Jinjuvadia R; Liangpunsakul S; Antaki F
J Clin Gastroenterol; 2014 Mar; 48(3):267-71. PubMed ID: 23751854
[TBL] [Abstract][Full Text] [Related]
2. Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study.
Stepanova M; Rafiq N; Younossi ZM
Gut; 2010 Oct; 59(10):1410-5. PubMed ID: 20660697
[TBL] [Abstract][Full Text] [Related]
3. Trends in Mortality From Extrahepatic Complications in Patients With Chronic Liver Disease, From 2007 Through 2017.
Kim D; Adejumo AC; Yoo ER; Iqbal U; Li AA; Pham EA; Cholankeril G; Glenn JS; Ahmed A
Gastroenterology; 2019 Oct; 157(4):1055-1066.e11. PubMed ID: 31251928
[TBL] [Abstract][Full Text] [Related]
4. Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016.
Kim D; Li AA; Gadiparthi C; Khan MA; Cholankeril G; Glenn JS; Ahmed A
Gastroenterology; 2018 Oct; 155(4):1154-1163.e3. PubMed ID: 30009816
[TBL] [Abstract][Full Text] [Related]
5. Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C.
Golabi P; Paik JM; Eberly K; de Avila L; Alqahtani SA; Younossi ZM
Ann Hepatol; 2022; 27(1):100556. PubMed ID: 34800721
[TBL] [Abstract][Full Text] [Related]
6. Mortality associated with alcohol-related liver disease.
Trimble G; Zheng L; Mishra A; Kalwaney S; Mir HM; Younossi ZM
Aliment Pharmacol Ther; 2013 Sep; 38(6):596-602. PubMed ID: 23889765
[TBL] [Abstract][Full Text] [Related]
7. In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not.
Younossi ZM; Otgonsuren M; Venkatesan C; Mishra A
Metabolism; 2013 Mar; 62(3):352-60. PubMed ID: 22999011
[TBL] [Abstract][Full Text] [Related]
8. Long-term prognostic value of the FibroTest in patients with non-alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver disease.
Munteanu M; Pais R; Peta V; Deckmyn O; Moussalli J; Ngo Y; Rudler M; Lebray P; Charlotte F; Thibault V; Lucidarme O; Ngo A; Imbert-Bismut F; Housset C; Thabut D; Ratziu V; Poynard T;
Aliment Pharmacol Ther; 2018 Nov; 48(10):1117-1127. PubMed ID: 30334263
[TBL] [Abstract][Full Text] [Related]
9. The presence of hepatitis B core antibody is associated with more advanced liver disease in alcoholic patients with cirrhosis.
Zhang M; Wu R; Jiang J; Minuk GY; Niu J
Alcohol; 2013 Nov; 47(7):553-8. PubMed ID: 24041840
[TBL] [Abstract][Full Text] [Related]
10. Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver Disease.
Younossi ZM; Stepanova M; Ong J; Yilmaz Y; Duseja A; Eguchi Y; El Kassas M; Castellanos-Fernandez M; George J; Jacobson IM; Bugianesi E; Wong VW; Arrese M; de Ledinghen V; Romero-Gomez M; Mendez-Sanchez N; Ahmed A; Wong R; Papatheodoridis G; Serfaty L; Younossi I; Nader F; Ziayee M; Afendy A;
Clin Gastroenterol Hepatol; 2019 Jul; 17(8):1625-1633.e1. PubMed ID: 30476585
[TBL] [Abstract][Full Text] [Related]
11. Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration.
Hunt CM; Beste LA; Lowy E; Suzuki A; Moylan CA; Tillmann HL; Ioannou GN; Lim JK; Kelley MJ; Provenzale D
World J Gastroenterol; 2016 May; 22(19):4732-40. PubMed ID: 27217704
[TBL] [Abstract][Full Text] [Related]
12. Predictors of chronic liver disease in individuals with human immunodeficiency virus infection.
Rafiq N; Stepanova M; Lam B; Nader F; Srishord M; Younossi ZM
Ann Hepatol; 2013 Jan-2014 Feb; 13(1):60-4. PubMed ID: 24378267
[TBL] [Abstract][Full Text] [Related]
13. Association between metabolic syndrome and its individual components with viral hepatitis B.
Jinjuvadia R; Liangpunsakul S
Am J Med Sci; 2014 Jan; 347(1):23-7. PubMed ID: 23514672
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States.
Golabi P; Paik J; Reddy R; Bugianesi E; Trimble G; Younossi ZM
BMC Gastroenterol; 2019 Apr; 19(1):56. PubMed ID: 30991959
[TBL] [Abstract][Full Text] [Related]
15. Trends in the prevalence of chronic liver disease in the Korean adult population, 1998-2017.
Park SH; Plank LD; Suk KT; Park YE; Lee J; Choi JH; Heo NY; Park J; Kim TO; Moon YS; Kim HK; Jang HJ; Park HY; Kim DJ
Clin Mol Hepatol; 2020 Apr; 26(2):209-215. PubMed ID: 31679316
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of chronic liver diseases in the USA in the past three decades.
Younossi ZM; Stepanova M; Younossi Y; Golabi P; Mishra A; Rafiq N; Henry L
Gut; 2020 Mar; 69(3):564-568. PubMed ID: 31366455
[TBL] [Abstract][Full Text] [Related]
17. Nonalcoholic Steatohepatitis Is Associated With Liver-Related Outcomes and All-Cause Mortality in Chronic Hepatitis B.
Choi HSJ; Brouwer WP; Zanjir WMR; de Man RA; Feld JJ; Hansen BE; Janssen HLA; Patel K
Hepatology; 2020 Feb; 71(2):539-548. PubMed ID: 31309589
[TBL] [Abstract][Full Text] [Related]
18. Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study.
Lazo M; Hernaez R; Bonekamp S; Kamel IR; Brancati FL; Guallar E; Clark JM
BMJ; 2011 Nov; 343():d6891. PubMed ID: 22102439
[TBL] [Abstract][Full Text] [Related]
19. Chronic Hepatitis B Prevalence Among Foreign-Born and U.S.-Born Adults in the United States, 1999-2016.
Le MH; Yeo YH; Cheung R; Henry L; Lok AS; Nguyen MH
Hepatology; 2020 Feb; 71(2):431-443. PubMed ID: 31228279
[TBL] [Abstract][Full Text] [Related]
20. Occult HBV infection in Morocco: from chronic hepatitis to hepatocellular carcinoma.
Kitab B; Ezzikouri S; Alaoui R; Nadir S; Badre W; Trepo C; Chemin I; Benjelloun S
Liver Int; 2014 Jul; 34(6):e144-50. PubMed ID: 24502524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
